REVIVA PHARMACEUTCLS HLDGS I (RVPHW)
Institutional ownership reported to the SEC as of Q3 2025, across 20 quarters.
2
Reporting holders
$10.8K
Reported value
0.0%
Held as options
-1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $10.8K | 134,668 | 0.00% | 2q | +785.9%+$9.6K |
| Virtu Financial LLC | $2 | 20,383 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2025 | 2 | $10.8K | 155,051 | 1 | 1 | 0 | 0.0% |
| Q2 2025 | 3 | $493 | 15,323 | 3 | 0 | 0 | 0.0% |
| Q1 2025 | 1 | $1 | 16,100 | 1 | 0 | 0 | 0.0% |
| Q4 2024 | 2 | $628 | 3,834 | 1 | 1 | 0 | 0.0% |
| Q3 2024 | 3 | $8.1K | 60,111 | 0 | 0 | 1 | 0.0% |
| Q2 2024 | 4 | $38.6K | 149,106 | 0 | 1 | 0 | 0.0% |
| Q1 2024 | 5 | $112.5K | 157,928 | 2 | 0 | 0 | 0.0% |
| Q4 2023 | 3 | $203.2K | 144,445 | 0 | 0 | 0 | 0.0% |
| Q3 2023 | 4 | $239.5K | 155,546 | 1 | 0 | 0 | 0.0% |
| Q2 2023 | 3 | $254.0K | 144,445 | 0 | 0 | 2 | 0.0% |
| Q1 2023 | 4 | $180.2K | 181,945 | 1 | 0 | 0 | 0.0% |
| Q4 2022 | 4 | $178.5K | 193,366 | 1 | 0 | 2 | 0.0% |
| Q3 2022 | 6 | $292.2K | 1,531,230 | 1 | 1 | 1 | 0.0% |
| Q2 2022 | 6 | $285.0K | 1,588,278 | 1 | 1 | 1 | 0.0% |
| Q1 2022 | 5 | $422.0K | 1,563,965 | 0 | 0 | 1 | 0.0% |
| Q4 2021 | 6 | $978.8K | 1,801,437 | 1 | 0 | 1 | 0.0% |
| Q3 2021 | 4 | $607.0K | 1,518,675 | 0 | 0 | 1 | 0.0% |
| Q2 2021 | 9 | $2.3M | 2,609,610 | 2 | 2 | 3 | 0.0% |
| Q1 2021 | 11 | $1.3M | 2,904,620 | 2 | 1 | 2 | 0.0% |
| Q4 2020 | 13 | $2.1M | 3,108,320 | 13 | 0 | 0 | 0.0% |